Analysts who follow Anika Therapeutics Inc (ANIK) on average expect it to fall -8.03% over the next twelve months. Those same analysts give the stock an average rating of Buy. That average rating earns Anika Therapeutics Inc an Analyst Ranking of 34, which means it ranks higher than 34 of stocks, based on data compiled by InvestorsObserver.
Wall Street analysts are rating ANIK a Buy today. Find out what this means to you and get the rest of the rankings on ANIK!